AbbVie
ABBV
#30
Rank
ยฃ242.50 B
Marketcap
ยฃ137.23
Share price
0.10%
Change (1 day)
13.05%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ108.72 Billion

According to AbbVie's latest financial reports the company's total liabilities are ยฃ108.72 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ97.57 B-2.85%
2022-12-31ยฃ100.44 B3.43%
2021-12-31ยฃ97.11 B-3.7%
2020-12-31ยฃ100.85 B35.94%
2019-12-31ยฃ74.19 B38.91%
2018-12-31ยฃ53.41 B9.89%
2017-12-31ยฃ48.60 B-2.42%
2016-12-31ยฃ49.81 B50.32%
2015-12-31ยฃ33.13 B100.19%
2014-12-31ยฃ16.55 B10.52%
2013-12-31ยฃ14.97 B2.38%
2012-12-31ยฃ14.62 B199.62%
2011-12-31ยฃ4.88 B38.77%
2010-12-31ยฃ3.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ100.46 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ60.53 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ48.51 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ65.98 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ28.60 B-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.46 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.24 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ50.75 B-53.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.64 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA